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ABSTRACT
Mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome is a multisystem disorder, which 
is clinically characterized by encephalopathy, dementia, seizures and stroke-like episodes. Multiple organs can be affected 
and cardiac involvement often dominates the clinical picture because of its high energy requirement. We report a case of a 
21-year-old woman with MELAS syndrome who had pre-excitation ECG and one episode of tachycardia attack. (Korean 
Circ J 2011;41:674-676)
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Introduction
Mitochondrial encephalopathy, lactic acidosis and stroke-
like episodes (MELAS) syndrome is a multisystem disorder, 
which is clinically characterized by encephalopathy, frequ-
ently manifesting as dementia, seizures and stroke-like epi-
sodes at a young age with evidence of mitochondrial dys-
function in the form of lactic acidosis and ragged-red fibers. 
Multiple organs can be affected, but tissues with high energy 
demand are the most vulnerable. Due to the high energy re-
quirement of cardiac muscles, cardiac disease features promi-
nently among the systemic manifestations of MELAS syn-
drome. Although cardiomyopathy is the most common car-
diac manifestation, Wolff-Parkinson-White (WPW) synd-
rome has also been reported in association with MELAS sy-
ndrome. We report a case of a WPW syndrome in a patient 
with MELAS syndrome.
Case
A 21-year-old woman was admitted to the hospital for a sei-
zure-like episode lasting for approximately five minutes and 
subsiding spontaneously. The patient had frequent and insi-
dious onset of seizure-like episodes, dysarthria, gait disturb-
ance and a right-sided visual field defect that had started four 
years ago without any history of essential hypertension, dia-
betes mellitus and dyslipidemia.
The patient initially presented with blood pressure of 111/ 
59 mm Hg, pulse rate of 109 beats/min, respiratory rate of 20/ 
min, and body temperature of 36.0°C. Laboratory results 
were raised cerebrospinal fluid (CSF) lactate of 5.2 mmol/L. 
Electroencephalography (EEG) showed diffuse cerebral dys-
function. Electromyography revealed sensorimotor polyneu-
ropathy and chronic myopathy. Brain MRI showed infarc-
tion in the right temporal lobe, ischemia in the left posterior 
frontoparietal cortex and basal ganglia, and cystic lesion in 
the pineal gland with brainstem and cerebellar atrophy (Fig. 
1). Biopsy of left vastus lateralis showed neurogenic atrophy 
and slightly increased lipid vacuoles without paracrystalline 
inclusion in the mitochondria (Fig. 2). Based on these clinical 
findings, the patient was diagnosed with MELAS syndrome.
Ten years later, she went to a dentist for treatment of dental 
caries. Five minutes after local anesthesia with lidocaine, her Min-Ho Lee, et al.   675
consciousness changed suddenly and she was urgently tr-
ansferred to the emergency room of our institution.
On arrival, she was stuporous with blood pressure of 209/ 
147 mm Hg, pulse rate of 140 beats/min, respiratory rate of 25/ 
min, and body temperature of 36.5°C. At that time, her elec-
trocardiography (ECG) showed supraventricular tachycar-
dia. After intravenous injections of 300 mg amiodarone, she 
recovered consciousness, and follow-up ECG showed sinus 
rhythm with pre-excitation (Fig. 3).
Transthoracic echocardiography revealed decreased early 
diastolic mitral annulus velocity (E’ velocity) and abnormal 
myocardial texture which were possibly associated with the 
initial phase of restrictive cardiomyopathy. Considering her 
bedridden status due to underlying MELAS syndrome, me-
dical treatment with propafenone was started. The patient was 
discharged and has been followed up without tachycardia 
attack.
Discussion
To the best of our knowledge, this is the first case to report 
on WPW syndrome in a patient with MELAS syndrome in 
the Korean literature. MELAS syndrome is a maternally inhe-
rited disorder caused by mutations of mitochondrial DNA 
that presents with a wide range of clinical expression. MELAS 
syndrome is clinically characterized by 1) encephalopathy, 
frequently manifesting as dementia, seizures, or both; 2) st-
roke-like episodes at a young age (typically by age 40 years); 
and 3) evidence of mitochondrial dysfunction in the form of 
lactic acidosis, ragged-red fibers or both.
1)
Age at onset was initially described to range from under 2 
years to over 60 years.
2) Multiple organs can be affected, but 
Fig. 1. Axial T2 brain MRI scan revealed infarction in the right 
temporal lobe, ischemia in the left posterior frontoparietal cortex 
and basal ganglia.
Fig. 2. Hematoxylin-eosin staining showed small angulated mus-
cle fibers with variations in size suggesting neurogenic atrophy 
and slightly increased lipid vacuoles in the subsarcolemmal area.
Fig. 3. Electrocardiography revealed a short PR interval, delta wave and widened QRS complex which were compatible with WPW syn-
drome.676   MELAS Syndrome
tissues with high energy demand are the most vulnerable. Th-
erefore, nervous system and muscle impairment often domi-
nate the clinical picture.
3) Cardiomyopathy is an early recogniz-
ed cardiac manifestation and is now a widely accepted com-
plication of MELAS syndrome. Kim et al.
4) reported the first 
case of myocardial involvement in a patient with MELAS syn-
drome in the Korean literature, and Son et al.
5) also reported 
a case of myocardial involvement in a patient with mitochon-
drial myopathy.
Conduction defects, including WPW syndrome, have also 
been reported in association with MELAS syndrome.
6) Recent-
ly, Sproule et al.
7) reported that four (13%) of 30 patients with 
MELAS syndrome had a clinical history of, or ECG findings 
consistent with, WPW syndrome.
Laboratory evaluation is a logical initial step in the diag-
nostic evaluation of suspected MELAS syndrome and an el-
evated level of lactate in the CSF is helpful. MRI is a power-
ful tool in the diagnostic evaluation of suspected cases of ME-
LAS syndrome. The Brain MRI of patients with MELAS syn-
drome typically demonstrates asymmetric lesions of the oc-
cipital and parietal lobes that mimic ischemia.
1)3) Muscle bio-
psy can be vital in the evaluation of MELAS syndrome. The 
presence of ragged red fibers on muscle biopsy is a classical 
finding and scattered vacuolated muscle fibers with a clear 
surrounding rim as well as the presence of many basophilic 
inclusions on microscopic examination.
6)
The percentage of heteroplasmy for a mitochondrial RNA 
mutation may vary widely depending on the specific tissue 
sampled.
8) Blood leukocyte samples have traditionally been 
the most common specimens, and urine sediment, cheek mu-
cosa and skin fibroblasts are often used and easily accessible 
alternate specimens.
9) Although the m.3243A>G common 
MELAS mutation is responsible for more than 80% of report-
ed MELAS cases,
1) most of these reports have come from Wes-
tern countries. Abu-Amero et al.
10) reported the case of a pa-
tient with typical clinical features of MELAS syndrome, but 
mutations in recognized genes were not identified.
Despite considerable advances in genetics and molecular 
biology, therapeutic options for MELAS syndrome remain li-
mited. Primary current treatment involves symptomatic ma-
nagement, in addition to supplementation with a so-called 
“mitochondrial cocktail”. Although recent studies of a poten-
tial therapeutic role for L-arginine have been promising, these 
observations needs to be confirmed by controlled trials.
6)
Because of significant morbidity and mortality, patients 
with MELAS syndrome should be screened at the time of di-
agnosis and followed regularly for the possibility of concurrent 
cardiac complications such as cardiomyopathy and WPW 
syndrome.
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